Scene Magazine – Sue Cullen
January 1, 2017

In the battle against cancer, patients and physicians now have available a new, unique molecular test that can predict whether a particular cancer will respond to chemotherapy, targeted therapy, or immunotherapy before a patient is treated. Dr. Steve Mamus, a Harvard-trained molecular biologist, has brought this powerful tool, GPS Cancer, to his practice at the Cancer Center of Sarasota-Manatee (CCSM).